XML 30 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHAREHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2022
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of stock options granted
   

Six months ended

June 30, 2022

 
 

 

Number

of options

 

 

Weighted

average

exercise

price

 

 

Weighted average

remaining contractual

term

(in years)

 

 

Aggregate

intrinsic

value

 

 

                         

Outstanding at beginning of year

   

5,186,446

   

$

3.40

     

4.01

   

$

534

 

Granted

   

155,000

     

1.80

               

Exercised

   

(88,115

)

   

1.29

               

Forfeited or expired

   

(673,118

)

   

5.43

               

 

                             

Outstanding at end of the period

   

4,580,213

     

3.09

     

3.78

   

$

472

 

 

                             

Options exercisable at end of the period

   

2,156,147

    $

2.90

     

2.63

   

$

250

 

 

                             

Vested and expected to vest

   

4,156,424

   

$

3.08

     

3.66

   

$

418

 
Schedule of RSUs granted
   

Number of RSUs

 

 

Aggregate

intrinsic value

 

 

               

Unvested at beginning of year

   

699,679

   

$

1,805

 

Granted

   

78,600

         

Vested

   

(12,312

)

   

 

 

Forfeited

   

(69,443

)

 

 

 

 

 

               

Unvested at end of period

   

696,524

    $

1,790

 
Schedule of equity-based compensation expense
   

Six months ended

June 30,

 
   

2021

   

2022

 
   

Unaudited

 

 

           

Cost of revenues

   

71

     

257

 

Research and development

   

113

     

20

 

Sales and Marketing

   

154

     

579

 

General and administrative

   

299

     

579

 

 

               

Total share-based compensation expense

 

$

637

   

$

1,435